TRCCC | Collaborative Immunotherapy Research
831794049
Pittsburgh, PA 15218 United States
trccc.org
TRCCC1998
Translational Research Cancer Center Consortium Inc
Overview
The Translational Research Cancer Center Consortium Inc., with an Employer Identification Number (EIN) of 831794049, is a nonprofit organization focused on advancing cancer research and treatment through translational approaches. The organization aims to improve the understanding of cancer by bridging basic scientific research with clinical applications.
Mission and Activities
The mission of the Translational Research Cancer Center Consortium Inc. is centered around facilitating the progression of cancer research, particularly in areas where there is a need for enhanced understanding and treatment. They focus on creating a collaborative environment where scientific discoveries can be swiftly translated into clinical trials and therapies, benefiting patients with various types of cancer.
Financial Operations
According to recent financial filings, the organization's revenue is primarily derived from program services, with no contributions from other sources such as investments or fundraising activities. The total assets of the organization have been reported to fluctuate over the years, reflecting the ebbs and flows of funding and operational costs typical of nonprofit research organizations.
Leadership and Governance
The leadership structure of the organization includes various roles such as President, Vice President, Treasurer, and Secretary. Notable figures have included individuals such as Michael T. Lotze and Elizabeth Repasky, who have held positions in the past.
Impact and Contributions
While specific details about the organization's research projects and clinical trials are not widely available, their focus on translational research aligns with broader efforts to improve cancer treatment outcomes by accelerating the transition from laboratory findings to clinical practices. This approach is critical in addressing the complex challenges posed by cancer and in contributing to the development of innovative therapies.
Conclusion
The Translational Research Cancer Center Consortium Inc. plays a role in the cancer research ecosystem by supporting the translation of scientific discoveries into practical applications for cancer patients. However, more detailed information about specific projects and achievements is necessary to fully assess its impact within the field.
[1] https://www.sitcancer.org/events/event-description?CalendarEventKey=5fd2b903-5719-4ec2-b284-0185972b02dc&Home=%2Fhome [2] https://trp.cancer.gov [3] https://projects.propublica.org/nonprofits/organizations/831794049 [4] https://tbcrc.org/about [5] https://tbcrc.org
Podobné organizace
Regional Cancer Center |
|
Hope Funds For Cancer Research |
|
Gateway for Cancer Research Inc. |
|
KURE IT INC |
|
ALLIANCE OF DEDICATED CANCER CENTERS INC |
Podobné organizace global
THE CANCER TREATMENT AND RESEARCH TRUST CIO |
|
INTERNATIONAL CANCER RESEARCH PARTNERSHIP |
|
THE TERRY FOX RESEARCH INSTITUTE |
|
TWO WORLDS CANCER COLLABORATION FOUNDATION |
|
Stand Up To Cancer Canada |
Podobně sociální sítě (195)
Více Rakovina
Umění proti rakovině, z.s.Praha |
|
Česká kooperativní skupina pro nádory hlavy a krku, z. s.Praha |
|
Nadační fond Pink BubblePraha |
|
Nadační fond pro protonovou terapiiPraha |
|
Nadační fond ÚSMĚVPlzeň |
Novinky
Check out this @KeystoneSymp with TRCCC founding member Betsy Repasky speaking Neural Influence on Cancer, Tumor Microenvironment and Cancer Immunology; January 18 - 21, 2025- Banff Springs, Alberta, Canada https://t.co/VBshzZczNL… #keystone #KSNeuroCancer25 (tw)
Looking for a postdoc? Dr. @craigmbrackett is hiring a postdoc fellow interested in the immune effects of TLR5 and radio- immunotherapy. https://t.co/kOLUy8iRAC (tw)
Poslední komentáře
So excited to see the TRCCC community growing! Welcome to UVA CCC! Together, we will make huge strides in cancer immunotherapy! 🌟💪detail |
|
The upcoming 2025 Annual Meeting sounds incredible! Can't wait to see what groundbreaking research comes from this collaboration. Let's keep pushing the boundaries of what's possible in cancer treatment! 🧬✨detail |
Poslední diskuze
What are the most promising recent advancements in cancer immunotherapy that could be highlighted during the upcoming TRCCC Annual Meeting in 2025?Odpovědí: 3, Naposledy před 1 den detail |
|
How can TRCCC member institutions effectively collaborate to enhance the understanding of the immune system's role in cancer progression and treatment?Odpovědí: 3, Naposledy před 1 den detail |
V okolí
4.5
Pittsburgh
O společnosti
- G30 -
Translational Research Cancer Centers ConsortiumExpediting Progress in Cancer Immunotherapy Home About Us Annual Meeting Job Board Sponsors Past Meetings Donate More TRCCC 2025 Details We are excited to announce that the 2025 Annual Meeting of the Translational Research Cancer Centers Consortium TRCCC will be held on February 1921 2025 at Seven Springs Mountain Resort in Champion PA. Registration and abstract submission will be opening on November 6 2024. Register soon. Fees for registration will increase after December 18 2024.
Rakovina